Buenos Aires (May 16, 2013).
ALIFAR, the Latin American generic pharmaceutical association, released a press release today announcing that it “decided to collectively support their associations from Chile, Mexico and Peru during TPP negotiations.” The announcement follows a three day meeting in Cartagena de Indias, Colombia. The release recounts that ALIFAR has issued a statement encouraging the Chilean, Mexican and Peruvian Governments “not to accept new and higher IP rights protection and enforcement standards that erode TRIPS’ flexibilities.” The statement continues:
“In that context, ALIFAR will join efforts with those advocacy groups sharing its strategic vision about intellectual property, access to medicines and public health.” Continue reading »





